Effect of Unani medicine in Stress urinary incontinence

Effect of ItrÄ«fal-i-SaghÄ«r in Stress Urinary Incontinence: A randomized controlled trial

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2022/02/040109

Enrollment

Registered

2022-02-08

Start date

Unknown

Completion date

Unknown

Last updated

2022-02-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N393- Stress incontinence (female) (male)

Interventions

Intervention1: Itrifal-i-Saghir: 10 gms of ItrÄ«fal-i-SaghÄ«r BD orally for 8 weeks Control Intervention1: Placebo resembling the intervention (Wheat flour mixture): 10 gms BD orally for 8 weeks

Eligibility

Inclusion criteria

Inclusion criteria: â??Women 20-60 years of age, with or without genital prolapse (Grade 1 and 2). â??Women who satisfy the criteria for Stress Urinary Incontinence according to MESA questionnaire.

Exclusion criteria

Exclusion criteria: Uncontrolled HTN, DM and Malignancies Pregnant and lactating women Neurological deficit incontinence (Stroke, spinal injury) UTI or fibroid/cyst >3cm or uterine prolapse (grade 3 and 4) History of medication/surgery for SUI in past three months

Design outcomes

Primary

Measure	Time frame
Change in MESA questionnaireTimepoint: Once a month during study along with pre and post test	—

Secondary

Measure	Time frame
Change in IIQ and UDI questionnaireTimepoint: Once a month and pre and post test	—

Countries

India

Contacts

Public ContactProfessor Wajeeha Begum

NIUM

drwajeehanium@gmail.com9972550185

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026